Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
4.3
-48.87%
40%
—
62.53%
60%
—
5 Years
Score4.3
Net Growth-48.87%
Net Trend40%
Net Income Consistency—
Rev Growth62.53%
Rev Trend60%
Revenue Consistency—
Pharming Group NV fundamental performance
Between 2020 and 2025, revenue grew from $ 212M to $ 376M and net income declined from $ 37M to $ 2M. Revenue increased in 3 of those 5 years; net income in 2.
Pharming Group NV currently holds a 5-year HDB Score of 4.3 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 11.83 | — |
1 Year2025-08-12 | $ 11.30 | 4.69% |
5 Years2021-08-12 | $ 10.45 | 13.21% |
All Time2020-12-23 | $ 16.70 | -29.16% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2020-12-23 |
|---|---|---|---|---|
| Price | $ 11.83 | $ 11.30 | $ 10.45 | $ 16.70 |
| Return | — | 4.69% | 13.21% | -29.16% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 366M | $ 9M | $ 158M |
| 2025 | $ 376M | $ 2M | $ 179M |
| 2024 | $ 307M | -$ 12M | $ 173M |
| 2023 | $ 245M | -$ 10M | $ 213M |
| 2022 | $ 205M | $ 13M | $ 207M |
| 2021 | $ 225M | $ 18M | $ 217M |
| IPO2020 | $ 212M | $ 37M | $ 167M |
Explore beyond PHAR
You're looking at Pharming Group NV. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
